Trial Profile
Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 02 Jun 2016 Planned initiation date changed from 1 Apr 2016 to 1 Jun 2016.
- 14 Apr 2016 New trial record